Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 50 (Search time: 0.036 seconds).
Item hits:
Issue DateTitleAuthor(s)
14-Dec-2015HIV-1/HAART-Related Lipodystrophy Syndrome (HALS) Is Associated with Decreased Circulating sTWEAK LevelsLópez Dupla, Miguel; Maymó Masip, Elsa; Martínez Chamorro, Esteban José; Domingo, Pere (Domingo Pedrol); Leal, Manuel; Peraire, Joaquim; Viladés, Consuelo; Veloso, Sergi; Arnedo, Mireia; Ferrando-Martínez, Sara; Beltrán-Debón, Raúl; Alba, Verónica; Gatell, José M.; Vendrell, Joan; Vidal, Francesc; Chacón, Matilde R.
27-Jan-2014Effect of Maraviroc intensification on HIV-1-specific T cell immunity in recently HIV-1-infected individualsKawana-Tachikawa, Ai; Llibre, Josep María; Bravo, Isabel; Escrig, Roser; Mothe, Beatriz; Puig, Jordi; Puertas, Maria C.; Martínez Picado, Francisco Javier; Blanco, Julià; Manzardo, Christian; Miró Meda, José M.; Iwamoto, Aikichi; Pozniak, Anton L.; Gatell, José M.; Clotet, Bonaventura, 1953-; Brander, Christian
17-Jul-2015Structured Treatment Interruptions and Low Doses of IL-2 in Patients with Primary HIV Infection. Inflammatory, Virological and Immunological OutcomesSued, Omar; Ambrosioni, Juan; Nicolás, David; Manzardo, Christian; Agüero Santangelo, Fernando; Claramonte, Xavier; Plana Prades, Montserrat; Tuset Creus, Montserrat; Pumarola Suñé, Tomàs; Gallart, Teresa; Gatell, José M.; Miró Meda, José M.
30-Dec-2015Mortality, Causes of Death and Associated Relate to a Large HIV Population-Based CohortGarriga, César; García de Olalla, Patricia; Miró Meda, José M.; Ocaña, Inma; Knobel Freud, Hernando Javier; Barberá, Maria Jesús; Humet, Victoria; Domingo, Pere (Domingo Pedrol); Gatell, José M.; Ribera, Esteban; Gurguí, Mercè; Marco, Andrés; Caylà i Buqueras, Joan A.
2010Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART studyGatell, José M.; INSIGHT STALWART Study Group
18-Oct-2016HIV-1 promonocytic and lymphoid cell lines: an in vitro model of in vivo mitochondrial and apoptotic lesion.Morén Núñez, Constanza; González Casacuberta, Ingrid; Álvarez Fernández, Carmen; Bañó, Maria; Catalán García, Marc; Guitart Mampel, Mariona; Juárez Flores, Diana Luz; Tobías, Ester; Milisenda, José; Cardellach, Francesc; Gatell, José M.; Sánchez-Palomino, Sonsoles; Garrabou Tornos, Glòria
30-Aug-2016Mitochondrial toxicity and caspase activation in HIV pregnant women.Hernández, Sandra; Morén Núñez, Constanza; Catalán García, Marc; López, Marta; Guitart Mampel, Mariona; Coll Escursell, Josep Oriol; García-Vega Redondo, Laura; Milisenda, José; Justamante, Ángela; Gatell, José M.; Cardellach, Francesc; Gratacós Solsona, Eduard; Miró i Andreu, Òscar; Garrabou Tornos, Glòria
12-Sep-2014HIV-1 DNA predicts disease progression and post-treatment virological controlWilliams, James P.; Hurst, Jacob; Stöhr, Wolfgang; Robinson, Nicola; Brown, Helen; Fisher, Martin; Kinloch, Sabine; Cooper, David A.; Schechter, Mauro; Tambussi, Giuseppe; Fidler, Sarah; Carrington, Mary; Babiker, Abdel; Weber, Jonathan; Koelsch, Kersten K.; Kelleher, Anthony D.; Phillips, Rodney E.; Frater, John; Miró Meda, José M.; Gatell, José M.; SPARTAC Trial Investigators
31-Jan-2014Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in EuropeZoufaly, Alexander; Cozzi-Lepri, Alessandro; Reekie, Joanne; Kirk, Ole; Lundgren, Jens D.; Reiss, Peter; Jevtovic, Djordje; Machala, Ladislav; Zangerle, Robert; Mocroft, Amanda; Van Lunzen, Jan 1963-; Miró Meda, José M.; Gatell, José M.
17-Mar-2014Clinically relevant transmitted drug resistance to first line antiretroviral drugs and implications for recommendationsMonge Corella, Susana; Guillot, Vicente; Alvarez, Marta; Chueca, Natalia; Stella, Natalia; Peña, Alejandro; Delgado, Rafael; Córdoba, Juan; Aguilera, Antonio (Aguilera Martín); Vidal Lancis, Maria Carmen; García, Federico; Miró Meda, José M.; Gatell, José M.